SEARCH LUMINIS HEALTH
Get stories & resources like this in your inbox
Sign up to stay up to date on the latest Luminis Health stories & news.
Sign Up
Hero Banner

Participants Needed For Reflux Study

Author

by Luminis Health

June 28, 2016
General - Tier 3 Section
antacid tablets

More than 60 million adults in the U.S. experience heartburn, the most common symptom of gastroesophageal reflux disease (GERD).

GERD is a digestive condition that causes indigestion and acid reflux. If you feel a burning sensation below your ribs or a sour taste at the back of your mouth after you eat, GERD may be to blame.

AAMC is participating in a clinical reflux study to compare treatment options for patients who continue to have symptoms, like heartburn and regurgitation, despite taking medication every day.

The study is comparing two treatment options for controlling reflux–a medical device, called LINX, and medications called Proton Pump Inhibitors (such as Nexium, Prevacid, and Priolosec) given two times per day.

  You may be eligible to participate in this study if you are 21 years or older and currently receive daily treatment for reflux symptoms. To determine if you’re eligible, additional testing will be required. For more information, please contact Almaz Holmatova, MD, study coordinator, at 443-481-4943 or [email protected].

 

Get stories & resources like this in your inbox
Sign up to stay up to date on the latest Luminis Health stories & news.
Sign Up